Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4.

Song T, Zhou H, Wei X, Meng Y, Guo Q

Open source

DOI
10.1038/s41417-020-00231-2
Published
2021 May
Container
Cancer gene therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41417-020-00231-2,
  title = {Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4.},
  author = {Song T and Zhou H and Wei X and Meng Y and Guo Q},
  year = {2021},
  journal = {Cancer gene therapy},
  doi = {10.1038/s41417-020-00231-2},
  url = {https://doi.org/10.1038/s41417-020-00231-2}
}

RIS

TY  - JOUR
TI  - Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4.
AU  - Song T
AU  - Zhou H
AU  - Wei X
AU  - Meng Y
AU  - Guo Q
PY  - 2021
JO  - Cancer gene therapy
DO  - 10.1038/s41417-020-00231-2
UR  - https://doi.org/10.1038/s41417-020-00231-2
ER  - 

APA

T, S., H, Z., X, W., Y, M., & Q, G. (2021). Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4.. Cancer gene therapy. https://doi.org/10.1038/s41417-020-00231-2

Source records